ARG82998

Human Dihydrotestosterone / DHT ELISA Kit

Human Dihydrotestosterone / DHT ELISA Kit for ELISA and Human

Signaling Transduction kit

Overview

Product Description ARG82998 Human Dihydrotestosterone / DHT ELISA Kit is an enzyme immunoassay kit for the quantification of 5α-Dihydrotestosterone in human serum and plasma.
Tested Reactivity Hu
Tested Application ELISA
Target Name Dihydrotestosterone / DHT
Conjugation HRP
Conjugation Note Substrate: TMB and read at 450 nm
Sensitivity 5.944 pg/ml
Sample Type Serum and plasma.
Standard Range 25 - 1500 pg/ml
Sample Volume 75 µl

Application Instructions

Assay Time 60, 15 min

Properties

Form 96 well
Storage Instruction Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Gene Full Name Dihydrotestosterone (DHT)
Background 5 alpha-dihydrotestosterone (DHT) is a steroid similar to testosterone and androstenedione, which belong to a class called androgens. DHT is a C19 steroid and possesses androgenic activity. The bulk of androgen production takes place mainly in the Leydig cells of the testes. Androgens circulate in the blood bound to proteins, especially sex hormone binding globulin (SHBG) and albumin. A trace amount of these steroids circulate in the unbound form in the blood and are referred to as the free fractions. DHT has at least three times the binding affinity for SHBG than testosterone. In males about 70% of DHT is derived from peripheral conversion of testosterone, while in females most of the DHT is derived from androstenedione. The major organ to neutralize androgens is the liver. Therefore in the liver the steroid hormones undergo structural modifications that are generally regarded as prerequisites for their biological inactivation. Some metabolites are formed and some are returned to the circulation before renal excretion. Therefore, elimination of steroids from the body is done through the urine.

Clinical Trends:

In Klinefelter's syndrome the DHT level is much lower than that found in normal men. In idiopathic hirsutism about 40% of the patients have an increased level of DHT. In polycystic ovaries (PCO) about 35% of the patients have an increased DHT level. The DHT level in young people is much higher than those found in normal older people, hence androgen production increases at puberty which gives rise to masculinizing characteristics. It has been demonstrated that the human testes produce DHT, which appears to originate in the seminiferous tubules. Therefore in tubular damage the production of DHT is impaired, which causes a decrease in the levels of plasma DHT (patients with germinal cell aplasia and azoospermia). There is a very low level of plasma DHT in patients with anorchia. It has been reported that in some prostate cancer (especially in stage D) the determination of DHT could be useful in predicting the response to anti-androgen therapy.
Highlight Related products:
Dihydrotestosterone antibodies; Dihydrotestosterone ELISA Kits;
New ELISA data calculation tool:
Simplify the ELISA analysis by GainData
Research Area Signaling Transduction kit

Images (1) Click the Picture to Zoom In

  • ARG82998 Human Dihydrotestosterone / DHT ELISA Kit example of standard curve image

    ARG82998 Human Dihydrotestosterone / DHT ELISA Kit results of a typical standard run with optical density reading at 450 nm.